Deepcell, a Spun out of Stanford University, is a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research.

Deepcell's mission is to enable novel biological insights at the single-cell level for improved diagnosis and treatment of disease.

Deepcell was founded in 2017, as a Spun out of Stanford University, by Maddison Masaeli and Mahyar Salek. The company is headquartered in Mountain View, California.


Deepcell offers an AI-powered imaging and microfluidics platform that identifies and isolates viable cells based on morphological distinctions for use in translational research, diagnostic testing, and therapeutics.


Deepcell is using deep learning and big data to classify and isolate individual cells from a sample. The technology combines advances in AI, cell capture, and single-cell analysis to sort cells based on detailed visual features, delivering novel insights through an unprecedented view of cell biology.


The Deepcell platform maintains cell viability for downstream single-cell analysis and can be used to isolate virtually any type of cell — even those occurring at frequencies as low as one in a billion- to offer access to rare cells and atypical cell states that will help advance precision medicine research.


Deepcell is backed by Andreessen Horowitz, Koch Disruptive Technologies, Bridger Healthcare, Horizons Ventures, Casdin Capital, Bow Capital, DCVC, and others. The company raised $73M in Series B round on Mar 17, 2022. This brings Deepcell's total funding to $98M to date.



  • Year founded: 2017
  • Funding Info: $98M over 4 Rounds (Latest Funding Type: Series B)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Mountain View
  • State: California
  • Country: United States
Related businesses